|
⚲
|
| Keyboard |
| David Mehalick | |
|---|---|
| Firm | |
| Address | 2868 Tiburon Blvd E Apt 103 Naples, FL 34109 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Jabez Biosciences Inc | 021-577807 | Promoter | 0.0 M | ||
| NOK Therapeutics Inc | 021-577751 | Promoter | 0.0 M of 0.0 M |
||
| NOK Therapeutics Inc | 021-562020 | Promoter | 0.3 M | ||
| NOK Therapeutics Inc | 021-562018 | Promoter | 0.6 M of 0.8 M |
||
| Jabez Biosciences Inc | 021-561483 | Promoter | 1.3 M of 3.0 M |
||
| Jabez Biosciences Inc | 021-561539 | Promoter | 0.3 M | ||
| Coeptis Therapeutics Holdings Inc | 021-553921 | Executive Officer | 4.0 M of 5.0 M |
||
| Coeptis Therapeutics Holdings Inc | 021-517161 | Executive Officer | 4.3 M of 10.0 M |
||
| Coeptis Therapeutics Holdings Inc | 021-496455 | Executive Officer | 2.0 M of 2.0 M |
||
| Coeptis Therapeutics Inc | 021-393300 | Executive Officer | 5.5 M of 9.0 M |
||
| Vinings Holdings Inc | 021-390507 | Executive Officer | |||
| Coeptis Pharmaceuticals Inc | 021-387690 | Executive Officer | 0.6 M of 5.0 M |
||
| Coeptis Pharmaceuticals Inc | 021-384011 | Executive Officer | 0.9 M of 0.9 M |
||
| Coeptis Pharmaceuticals Inc | 021-326656 | Executive Officer | of 18.0 M |
||